CHROMOGENICS PUBLISHES PROSPECTUS RELATING TO THE RIGHTS ISSUE
PRESS RELEASE THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN CHROMOGENICS AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW.ChromoGenics AB (publ) ("ChromoGenics" or the "Company") announces that the prospectus relating to the Company’s